Stay up to date

The Global Forum on TB Vaccines is the world’s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the field, share the latest research findings, and identify new and innovative approaches to TB vaccine R&D, with the end goal of developing and deploying new TB vaccines as quickly as possible. The Global Forum program addresses the full spectrum of issues relevant to TB vaccine research and development (R&D), from basic research to clinical trials, manufacturing, regulatory, access, and advocacy.

Due to the ongoing coronavirus pandemic, a Virtual Global Forum on TB Vaccines will be convened from 20 - 22 April 2021. It will provide an overview of the state of the field and recent progress in TB vaccine R&D against the backdrop of the COVID-19 pandemic; and convene researchers, developers, funders and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.

To register visit https://tbvaccinesforum.org/register/

This year’s edition of INTEREST will be held as a virtual meeting from 12 – 14 October. Dr. Andrew Kambugu, a member of the International Conference Committee (ICC), shares his thoughts on why you should join this important meeting.

Young Investigators
The registration fee is waived for all Young Investigators. To be eligible as a young investigator, one should be:
- 35 years of age or younger; and
- a current Master/PhD student OR have obtained an MD/PharmD/PhD degree in the last five years.
An application form needs to be completed by a supervisor and received by the Conference Secretariat at Lara.daSilvaMiguel@amededu.com.

Resource-Limited Settings
In addition, we are pleased to provide a discounted registration fee for all healthcare professionals, NGO/GO representatives, and advocates from resource-limited settings. This is available when completing the registration

For more information visit http://interestconference.org/

The LiberHetica and BERC-Luso consortia will meet on the 26th March 2021 to discuss about Biomedical Ethics and Regulatory Capacity Building in Sub-Saharan African countries.
The BERC-Luso and LiberHetica are two projects funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) aimed at strenghting ethics and regulatory capacities for clinical trials by partnerships between African and European countries, and involving 5 Sub-Saharan African countries (Liberia, Angola, Guinea Bissau, Mozambique and Cape-Verde) and 2 European countries (U.K. and Portugal).

For more information visit https://www.liberhetica.org/2021/03/09/biomedical-ethics-and-regulatory-capacity-building-international-dialogues/

The Global Forum on Bioethics in Research (GFBR) will hold a two-day meeting in Montreux, Switzerland on 28-29 November 2023 on the topic: “The ethics of health research priority setting”. The Forum prioritises the participation of colleagues from low- and middle- income countries (LMICs), and a call for applications is open with a deadline of 15 May 2023.

More information https://www.gfbr.global/news/gfbr-2023-call-for-applications-now-open/